• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,631.65 -931.25
( -1.20%)
Global Indices
Nasdaq
47,935.11 1,329.65
(2.85%)
Dow Jones
6,804.45 166.60
(2.51%)
Hang Seng
55,958.99 -349.43
(-0.62%)
Nikkei 225
10,579.52 -29.36
(-0.28%)
Forex
USD-INR
92.90 -0.03
(-0.03%)
EUR-INR
107.45 0.22
(0.21%)
GBP-INR
123.16 0.23
(0.18%)
JPY-INR
0.58 0.00
(-0.10%)

EQUITY - MARKET SCREENER

Amerise Biosciences Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
531681
INE673C01020
0.8066415
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
67
4.43
EPS(TTM)
Face Value()
Div & Yield %
0.01
1
0
 

NACL Industries approves terms of rights issue
Dec 08,2025
NACL Industries has approved the terms of rights issue as under:

(a) Instrument: Fully paid-up Equity Shares of face value of Re. 1 each;
(b) Total number of Rights Equity Shares and the Rights Issue size: 3,25,01,851 Rights Equity Shares each on fully paid-up basis for an amount aggregating up to Rs 2,49,28,91,971.70 (assuming full subscription with respect to Rights Equity Shares);
(c) Rights Issue Price: Rs 76.70 per Rights Equity Share (including a premium of Rs 75.70 per Rights Equity Share) on application.
(d) Record date: Friday, December 12,2025
(e) Rights entitlement ratio: 05 (Five) Rights Equity Shares for every 31 (Thirty-One) fully paid up Equity Shares held by the eligible Equity Shareholders of the Company as on the Record Date

(f) Rights Issue Opening Date: Monday, December 22,2025;
(g) On-market renunciation period Start: Monday, December 22,2025;
(h) On-market renunciation period End: Wednesday, December 24,2025 ;
(i) Rights Issue Closing Date: Tuesday, December 30,2025